These are all the variants already in the USA with an estimated growth advantage ***higher*** than BA.2.86.1, which according to covSPECTRUM already has a >53% advantage over the absolute baseline.
JN.1 is at the top with an estimated growth advantage of >130%.
Not nearly enough people caring about these COVID vaccinations. Gonna be a wacky winter.


